Showing results (21-30 of 582) with videos related to
Sort By:
Pageof 59
European Cytokine Network|March 8, 2000
Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1aP Perini, M Tiberio, S Sivieri, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2008
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging studyM Calabrese, M Filippi, M Rovaris, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 1998
Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patientsA M Ferrarini, S Sivieri, M Buttarello, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological surveyF Ranzato, P Perini, E Tzintzeva, et al.Journal of Neuroimmunology|March 14, 2000
Effect of IFNbeta and anti-IFNbeta antibodies on NK cells in multiple sclerosis patientsP Perini, M Wadhwa, M Buttarello, et al.European Cytokine Network|April 3, 2001
Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivoP Perini, A Facchinetti, P Bulian, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Cyclophosphamide-based combination therapies for autoimmunityPaola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.Expert Opinion on Drug Safety|March 21, 2007
The safety profile of cyclophosphamide in multiple sclerosis therapyPaola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.Neurology|August 27, 2010
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosisM Calabrese, M Battaglini, A Giorgio, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2009
Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosisFrancesca Rinaldi, Paola Perini, Massimiliano Calabrese, et al.Pageof 59